Published in Am J Gastroenterol on June 01, 1999
Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease. Gastroenterology (2008) 6.15
Liver enzyme alteration: a guide for clinicians. CMAJ (2005) 3.42
Clinical Monitoring of Chronic Hepatitis C Based on its Natural History and Therapy. N Am J Med Sci (Boston) (2014) 0.88
APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing. Hepatol Int (2016) 0.79
Thyroid disease in chronic hepatitis C infection treated with combination interferon-α and ribavirin: management strategies and future perspective. Endocr Pract (2013) 0.77
Diagnostic and mechanistic implications of serum free light chains, albumin and alpha-fetoprotein in hepatocellular carcinoma. Br J Cancer (2014) 0.77
Development of Serum DHCR24 Antibody as a Marker for Hepatocellular Carcinoma: The End of the Beginning. EBioMedicine (2015) 0.75
A Point System to Forecast Hepatocellular Carcinoma Risk Before and After Treatment Among Persons with Chronic Hepatitis C. Dig Dis Sci (2017) 0.75
Missed diagnoses of acute cardiac ischemia in the emergency department. N Engl J Med (2000) 9.52
Interference with cardiac pacemakers by cellular telephones. N Engl J Med (1997) 3.45
End-of-life care in the pediatric intensive care unit after the forgoing of life-sustaining treatment. Crit Care Med (2000) 3.26
Cloning and characterization of a Pseudomonas mendocina KR1 gene cluster encoding toluene-4-monooxygenase. J Bacteriol (1991) 3.01
Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. N Engl J Med (1984) 2.76
Use of the acute cardiac ischemia time-insensitive predictive instrument (ACI-TIPI) to assist with triage of patients with chest pain or other symptoms suggestive of acute cardiac ischemia. A multicenter, controlled clinical trial. Ann Intern Med (1998) 2.58
Patient-specific predictions of outcomes in myocardial infarction for real-time emergency use: a thrombolytic predictive instrument. Ann Intern Med (1997) 2.52
Perinatal hepatitis B virus transmission in the United States. Prevention by passive-active immunization. JAMA (1985) 2.48
Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China. Cancer Res (1989) 2.35
Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States. J Natl Cancer Inst (1990) 2.23
Sequence and analysis of chromosome 3 of the plant Arabidopsis thaliana. Nature (2000) 2.17
The use of empiric clinical data in the evaluation of practice guidelines for unstable angina. JAMA (1996) 2.09
Yeast-recombinant hepatitis B vaccine. Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission. JAMA (1987) 2.08
Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. Consensus Interferon Study Group. J Gastroenterol Hepatol (2000) 2.06
Surveillance for hepatocellular carcinoma in patients with chronic viral hepatitis in the United States of America. J Gastroenterol Hepatol (2001) 2.06
Coagulation defects associated with massive blood transfusions. Ann Surg (1971) 2.03
Hepatitis-associated antigen and hepatocellular carcinoma in Taiwan. Ann Intern Med (1971) 1.89
Intrahepatic, nucleocapsid antigen-specific T cells in chronic active hepatitis B. J Immunol (1987) 1.85
End-of-life care in the pediatric intensive care unit: attitudes and practices of pediatric critical care physicians and nurses. Crit Care Med (2001) 1.64
Inflammation and cardiovascular events in individuals with and without chronic kidney disease. Kidney Int (2008) 1.64
Lymphocyte stimulation in hepatitis B infections. N Engl J Med (1975) 1.60
Racial differences in responses to therapy with interferon in chronic hepatitis C. Consensus Interferon Study Group. Hepatology (1999) 1.59
Septic complications of war wounds. JAMA (1972) 1.58
Lack of response to recombinant hepatitis B vaccine in nonresponders to the plasma vaccine. JAMA (1988) 1.56
Acute cardiac ischemia in patients with cocaine-associated complaints: results of a multicenter trial. Ann Emerg Med (2000) 1.51
Nonviral risk factors for hepatocellular carcinoma in a low-risk population, the non-Asians of Los Angeles County, California. J Natl Cancer Inst (1991) 1.50
Assessment of hepatitis C virus RNA and genotype from 6807 patients with chronic hepatitis C in the United States. J Viral Hepat (2000) 1.45
Dextromethorphan-induced mania. Psychosomatics (1996) 1.45
Perinatal transmitted acute icteric hepatitis B in infants born to hepatitis B surface antigen-positive and anti-hepatitis Be-positive carrier mothers. Pediatrics (1982) 1.44
Autoimmune cholangitis with features of autoimmune hepatitis: successful treatment with immunosuppressive agents and ursodeoxycholic acid. J Gastroenterol Hepatol (2000) 1.40
The long-term outcomes of patients with compensated hepatitis C virus-related cirrhosis and history of parenteral exposure in the United States. Hepatology (1999) 1.39
Primary hepatocellular carcinoma following perinatal transmission of hepatitis B. West J Med (1988) 1.38
Twenty years of the German Environmental Survey (GerES): human biomonitoring--temporal and spatial (West Germany/East Germany) differences in population exposure. Int J Hyg Environ Health (2007) 1.30
Clinical and bacteriological evaluation of antibiotic treatment in shigellosis. JAMA (1970) 1.29
Predicting recovery of severe regional ventricular dysfunction. Comparison of resting scintigraphy with 201Tl and 99mTc-sestamibi. Circulation (1994) 1.29
Treatment of chronic hepatitis C with consensus interferon: a multicenter, randomized, controlled trial. Consensus Interferon Study Group. Hepatology (1997) 1.25
German health-related environmental monitoring: assessing time trends of the general population's exposure to heavy metals. Int J Hyg Environ Health (2013) 1.23
Evaluation of hepatitis B and C viral markers: clinical significance in Asian and Caucasian patients with hepatocellular carcinoma in the United States of America. J Gastroenterol Hepatol (1996) 1.21
Prediction of response during interferon alfa 2b therapy in chronic hepatitis C patients using viral and biochemical characteristics: a comparison. Hepatology (1997) 1.17
Patients co-infected with human immunodeficiency virus and hepatitis C virus demonstrate higher levels of hepatic HCV RNA. J Viral Hepat (1999) 1.16
A comparative study of hepatitis B viral markers in the family members of Asian and non-Asian patients with hepatitis B surface antigen-positive hepatocellular carcinoma and with chronic hepatitis B infection. J Infect Dis (1979) 1.15
Prevention of maternal-infant hepatitis B virus transmission by immunization: the role of serum hepatitis B virus DNA. Hepatology (1986) 1.13
A comparison of logistic regression to decision-tree induction in a medical domain. Comput Biomed Res (1993) 1.12
Presentations of acute myocardial infarction in men and women. J Gen Intern Med (1997) 1.11
Differences in eye-hand motor coordination of video-game users and non-users. Percept Mot Skills (1983) 1.09
Regulation of hepatic glycogen synthetase. Stimulation of glycogen synthetase in an in vitro liver system by insulin bound to sepharose. J Biol Chem (1971) 1.09
Alterations in the immune response of nonresponders to the hepatitis B vaccine. J Infect Dis (1985) 1.07
Re-treatment of chronic hepatitis C with consensus interferon . Hepatology (1998) 1.05
A twenty-year experience with surgical management of carcinoma of the esophagus and gastric cardia. J Thorac Cardiovasc Surg (1980) 1.05
A comparison of interferon-Con1 with natural recombinant interferons-alpha: antiviral, antiproliferative, and natural killer-inducing activities. J Interferon Res (1992) 1.04
Immunological studies in familial primary biliary cirrhosis. Gastroenterology (1976) 1.04
Cloning and characterization of a new member of the Nudix hydrolases from human and mouse. J Biol Chem (2000) 1.03
Inhibition of hepatitis C virus (HCV)-RNA-dependent translation and replication of a chimeric HCV poliovirus using synthetic stabilized ribozymes. Hepatology (2000) 1.03
Liver involvement in sickle cell disease. Medicine (Baltimore) (1985) 1.00
Analysis of the viability of freezer stored serum samples for hepatitis C virus RNA analysis by the SUPERQUANT method: results of a 16 year retrospective study. J Virol Methods (1999) 0.99
Is there an optimal time to measure quantitative HCV RNA to predict non-response following interferon treatment for chronic HCV infection? J Hepatol (1998) 0.98
Nuclease-resistant synthetic ribozymes: developing a new class of therapeutics. J Clin Invest (2000) 0.98
Unimpaired B-cell function and T-cell regulation of immunoglobulin synthesis in patients with chronic hepatitis B virus infection. Clin Immunol Immunopathol (1982) 0.98
The natural course of hepatitis B surface antigen-positive chronic active hepatitis in Taiwan. J Infect Dis (1982) 0.98
A time-insensitive predictive instrument for acute myocardial infarction mortality: a multicenter study. Med Care (1991) 0.98
Vibrio vulnificus infection after raw oyster ingestion in a patient with liver disease and acquired immune deficiency syndrome-related complex. Gastroenterology (1987) 0.98
Malabsorption in Plasmodium falciparum malaria. Am J Trop Med Hyg (1972) 0.97
Studies on the maternal-infant transmission of the hepatitis B virus and HBV infection within families. Prog Med Virol (1981) 0.97
[Morphology of cavernous transformation of the portal vein (author's transl)]. Leber Magen Darm (1980) 0.95
Adriamycin and methyl-CCNU combination therapy in hepatocellular carcinoma: clinical and pharmacokinetic aspects. Cancer (1981) 0.95
Pharmacokinetics and tissue distribution of a ribozyme directed against hepatitis C virus RNA following subcutaneous or intravenous administration in mice. Hepatology (2000) 0.95
Genes involved in the determination of the rate of inversions at short inverted repeats. Genes Cells (2000) 0.95
Immunological response in leptospirosis. Report of three cases. Am J Trop Med Hyg (1971) 0.95
Trends in indications and outcomes in the Whipple procedure over a 40-year period. Am Surg (1999) 0.95
Pulmonary involvement in primary biliary cirrhosis. J Clin Gastroenterol (1987) 0.94
Type 1 interferon as an antiinflammatory agent: inhibition of lipopolysaccharide-induced interleukin-1 beta and induction of interleukin-1 receptor antagonist. J Interferon Cytokine Res (1995) 0.93
Reduction of temporal lobe volume in bipolar disorder: a preliminary report of magnetic resonance imaging. Arch Gen Psychiatry (1991) 0.93
Comparison of three different hybridization assays in the quantitative measurement of serum hepatitis B virus DNA. J Virol Methods (1996) 0.93
Ultracentrifugation and concentration of a large volume of serum for HCV RNA during treatment may predict sustained and relapse response in chronic HCV infection. J Med Virol (1999) 0.92
Intrathecal IgG synthesis and albumin leakage are increased in subjects with HIV-1 neurologic disease. J Acquir Immune Defic Syndr (1994) 0.92
Liver transplantation for chronic hepatitis B in Asians. Transplantation (1994) 0.92
Antibiotic sensitivities of shigella isolates in Vietnam, 1968-1969. Mil Med (1970) 0.92
Risk factors for hepatitis C virus infection among health care personnel in a community hospital. Am J Infect Control (1993) 0.92
Regulation of hepatic glycogen synthetase of Rana catesbeiana. Inhibition of the action of insulin by ouabain. J Biol Chem (1972) 0.92
MRI-based measurements of temporal lobe and ventricular structures in patients with bipolar I and bipolar II disorders. J Affect Disord (2000) 0.92
Effects of short-term, high-dose prednisone treatment of patients with HBsAg-positive chronic active hepatitis. Liver (1985) 0.92
Hospital mortality in women and men with acute cardiac ischemia: a prospective multicenter study. J Am Coll Cardiol (1997) 0.91
Lavage to remove enteric-coated aspirin and gastric outlet obstruction. Ann Intern Med (1977) 0.90
Early hepatitis C virus-RNA responses predict interferon treatment outcomes in chronic hepatitis C. The Consensus Interferon Study Group. Hepatology (1998) 0.90
Causes of chest pain and symptoms suggestive of acute cardiac ischemia in African-American patients presenting to the emergency department: a multicenter study. J Natl Med Assoc (1997) 0.90
Characterization of nuclease-resistant ribozymes directed against hepatitis B virus RNA. J Viral Hepat (2002) 0.90
Serious injuries and deaths of adolescent girls resulting from interpersonal violence: characteristics and trends from the United States, 1989-1998. Arch Pediatr Adolesc Med (2001) 0.89
Acute cardiac ischemia in patients with syncope: importance of the initial electrocardiogram. J Gen Intern Med (1992) 0.89